HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne-Lise Børresen-Dale Selected Research

human MIRN663 microRNA

12/2011Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne-Lise Børresen-Dale Research Topics

Disease

138Breast Neoplasms (Breast Cancer)
01/2022 - 04/2002
131Neoplasms (Cancer)
01/2022 - 10/2002
10Carcinogenesis
01/2016 - 11/2005
7Neoplasm Metastasis (Metastasis)
10/2019 - 02/2007
7Carcinoma (Carcinomatosis)
01/2016 - 07/2004
5Genomic Instability
11/2018 - 11/2006
5Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 01/2009
5Triple Negative Breast Neoplasms
01/2016 - 06/2010
4Colorectal Neoplasms (Colorectal Cancer)
07/2020 - 12/2002
4Noninfiltrating Intraductal Carcinoma (DCIS)
01/2019 - 02/2012
3Fibrosis (Cirrhosis)
03/2011 - 07/2007
2Residual Neoplasm
01/2021 - 11/2020
2Adenocarcinoma
01/2017 - 01/2016
2Lymphatic Metastasis
12/2016 - 06/2004
2Circulating Neoplastic Cells
10/2016 - 08/2009
2Activated Protein C Resistance (APC Resistance)
09/2016 - 11/2014
2Lung Neoplasms (Lung Cancer)
01/2016 - 10/2014
2Hypoxia (Hypoxemia)
08/2015 - 03/2006
2Radiation Fibrosis Syndrome (Radiation Fibrosis)
03/2011 - 03/2008
2Long Term Adverse Effects
03/2008 - 03/2007
1Pathologic Complete Response
01/2021
1Hypertension (High Blood Pressure)
11/2020
1Infections
11/2020
1Hemorrhage
11/2020
1Febrile Neutropenia
11/2020
1Colitis
07/2020
1Inflammation (Inflammations)
01/2017

Drug/Important Bio-Agent (IBA)

41DNA (Deoxyribonucleic Acid)IBA
09/2021 - 10/2002
32Phenobarbital (Luminal)FDA Link
09/2021 - 07/2003
27Estrogen ReceptorsIBA
01/2022 - 10/2004
27Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2003
27Messenger RNA (mRNA)IBA
01/2019 - 10/2002
20MicroRNAs (MicroRNA)IBA
01/2021 - 01/2008
20Biological ProductsIBA
01/2020 - 04/2002
19Biomarkers (Surrogate Marker)IBA
11/2020 - 01/2009
11Hormones (Hormone)IBA
01/2021 - 02/2006
11RNA (Ribonucleic Acid)IBA
01/2019 - 10/2002
9Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 07/2008
9Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014 - 11/2003
8Complementary DNA (cDNA)IBA
11/2006 - 10/2002
7Bevacizumab (Avastin)FDA Link
01/2021 - 02/2013
7Polysaccharides (Glycans)IBA
01/2018 - 04/2010
7Estrogens (Estrogen)FDA Link
01/2017 - 01/2005
6Fluorouracil (Carac)FDA LinkGeneric
11/2018 - 11/2003
6Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2014 - 11/2003
5human ERBB2 proteinIBA
01/2022 - 06/2010
5Transcription Factors (Transcription Factor)IBA
11/2017 - 03/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 06/2015
4CytokinesIBA
01/2019 - 01/2016
4ChromatinIBA
05/2016 - 02/2008
4Epidermal Growth Factor (EGF)IBA
01/2016 - 06/2010
4EnzymesIBA
01/2010 - 01/2004
3Estrogen Receptor betaIBA
11/2019 - 01/2004
3lipoprotein-associated coagulation inhibitor (TFPI)IBA
09/2016 - 11/2014
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016 - 04/2010
3Estradiol (Delestrogen)FDA LinkGeneric
08/2011 - 01/2004
2Immune Checkpoint InhibitorsIBA
07/2020 - 01/2019
2Small Interfering RNA (siRNA)IBA
01/2019 - 04/2011
2Aromatase InhibitorsIBA
01/2019 - 05/2005
2Pharmaceutical PreparationsIBA
01/2019 - 01/2008
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2018 - 06/2009
2NucleotidesIBA
10/2017 - 07/2010
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2017 - 11/2010
2Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2017 - 11/2010
2Protein SIBA
09/2016 - 11/2014
2AntithrombinsIBA
09/2016 - 11/2014
2fibrin fragment D (D-dimer)IBA
09/2016 - 11/2014
2Protein CIBA
09/2016 - 11/2014
2ORALIT (ORS)IBA
05/2016 - 11/2014
2Mitochondrial DNA (mtDNA)IBA
01/2016 - 01/2015
2Oxidoreductases (Dehydrogenase)IBA
07/2015 - 01/2004
2Thromboplastin (Tissue Factor)IBA
03/2015 - 11/2014
2Choline (Choline Chloride)IBA
01/2014 - 08/2010
21,3,4,5,6-pentachlorocyclohexene-1-oxideIBA
01/2014 - 08/2010
2AnthracyclinesIBA
07/2010 - 11/2003
2Glutathione Transferase (Glutathione S-Transferase)IBA
07/2008 - 03/2007
2Carrier Proteins (Binding Protein)IBA
11/2007 - 05/2005
2Estrogen Receptor alphaIBA
11/2007 - 01/2004
2Codon (Codons)IBA
07/2004 - 12/2002
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
01/2020
1Becaplermin (PDGF-BB)FDA Link
01/2019
1Cell-Free Nucleic AcidsIBA
01/2019
1Interferon-gamma (Interferon, gamma)IBA
01/2019
1ProteomeIBA
01/2019
1Angiogenesis InhibitorsIBA
01/2019
1pembrolizumabIBA
01/2019
1Circular RNAIBA
01/2019
1Epirubicin (Ellence)FDA LinkGeneric
11/2018
1taxaneIBA
11/2018
1Mannose (D-Mannose)IBA
01/2018
1Glycoproteins (Glycoprotein)IBA
10/2017
1Tumor Biomarkers (Tumor Markers)IBA
10/2016

Therapy/Procedure

33Therapeutics
01/2021 - 11/2003
17Drug Therapy (Chemotherapy)
01/2021 - 11/2003
11Neoadjuvant Therapy
01/2021 - 07/2003
8Radiotherapy
10/2017 - 01/2004
3Aftercare (After-Treatment)
10/2019 - 06/2004
2Adjuvant Radiotherapy
03/2011 - 03/2007
1Combined Modality Therapy
10/2017
1Adjuvant Chemotherapy
01/2017